Ticker Details
ZOETIS INC. Zoetis Inc is a developer and manufacturer of drugs providing medicines for animal health, and vaccines for livestock and companion animals. Its products are anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.
IPO Date:	February 1, 2013
Sector:	Healthcare
Industry:	Drug Manufacturers
Market Cap:	$32.12B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.24 | 1.10%
Avg Daily Range (30 D):	$1.43 | 1.90%
Avg Daily Range (90 D):	$1.66 | 1.94%

Institutional Daily Volume
Avg Daily Volume:	2.58M
Avg Daily Volume (30 D):	5.31M
Avg Daily Volume (90 D):	5.62M

Trade Size
Avg Trade Size (Sh.):	90
Avg Trade Size (Sh.) (30 D):	73
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	29,588
Avg Institutional Trade:	$7.99M
Avg Institutional Trade (30 D):	$7.57M
Avg Institutional Trade (90 D):	$7.9M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	8

Market Closing Trades
Avg Closing Trade:	$36.21M
Avg Closing Trade (30 D):	$70.17M
Avg Closing Trade (90 D):	$81.98M
Avg Closing Volume:	321.49K

News

Jul 27, 2026 @ 2:49 PM DEADLINE ALERT for AVAV, CALX, ZTS, and LCID: The ... Source: The Law Offices Of Frank R. Cruz

Jul 23, 2026 @ 3:10 AM ZOETIS DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR... Source: Rosen Law Firm

Jul 20, 2026 @ 9:50 PM ZOETIS CLASS ACTION DEADLINE MONDAY JULY 27th: Bra... Source: Bragar Eagel & Squire, P.C.

Jul 20, 2026 @ 5:53 PM Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who... Source: Glancy Prongay Wolke & Rotter Llp

Jul 19, 2026 @ 11:47 PM ZOETIS DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSE... Source: Rosen Law Firm

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$6.08	$1.65	$1.42
Diluted EPS	$6.07	$1.65	$1.42
Revenue	$9.52B	$2.47B	$2.26B
Gross Profit	$6.81B	$1.8B	$1.62B
Net Income / Loss	$2.62B	$691M	$601M
Operating Income / Loss	$3.27B	$866M	$758M
Cost of Revenue	$2.71B	$673M	$641M
Net Cash Flow	$-167M	$-465M	$-509M
PE Ratio